Adage Capital Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
830,000
-447,000
| -35% | -$6.12M | 0.02% | 588 |
|
|
2025
Q1 | $14.1M | Sell |
1,277,000
-1,651,086
| -56% | -$18.3M | 0.03% | 502 |
|
|
2024
Q4 | $31.2M | Sell |
2,928,086
-807,655
| -22% | -$8.6M | 0.05% | 317 |
|
|
2024
Q3 | $47.4M | Buy |
3,735,741
+435,741
| +13% | +$5.53M | 0.08% | 242 |
|
|
2024
Q2 | $55.4M | Buy |
3,300,000
+2,000,000
| +154% | +$33.6M | 0.1% | 203 |
|
|
2024
Q1 | $19.5M | Buy |
+1,300,000
| New | +$19.5M | 0.04% | 458 |
|